Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Vireo Growth Completes Hawthorne Gardening Acquisition and Equity Issuance

Tipranks - Wed Apr 15, 3:34PM CDT

Claim 30% Off TipRanks

Vireo Growth ( (TSE:VREO) ) has issued an update.

On April 8, 2026, Vireo Growth Inc. completed the acquisition of The Hawthorne Gardening Company from The Scotts Miracle-Gro Company, adding a leading North American supplier of nutrients, lighting, and other indoor and hydroponic gardening materials to its platform. The deal delivers roughly US$35 million in cash, about US$58 million in net working capital, and US$20 million in inventory over two years, further bolstering Vireo’s balance sheet and procurement capabilities.

In exchange, Vireo issued 213 million subordinate voting shares at a deemed price of US$0.60 and granted 80 million warrants exercisable at US$0.85 for five years to Scotts’ designee, Good Dog Holdings LLC, which now owns about 14% of the company and could rise to about 19% on full warrant exercise. Vireo has also nominated Scotts executive vice president and Hawthorne lead Chris Hagedorn for election to its board, a move that deepens strategic ties with Scotts and may enhance integration and operational execution across Vireo’s expanding portfolio.

More about Vireo Growth

Vireo Growth Inc., founded in 2014, is a medical cannabis company building a disciplined, execution-focused platform with a strong local market focus supported by a national portfolio. The company emphasizes strategic capital deployment, supply-chain optimization, and long-term value creation for customers, employees, shareholders, partners, and the communities it serves.

Average Trading Volume: 40,182

Technical Sentiment Signal: Strong Sell

Current Market Cap: C$572.6M

See more data about VREO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.